# Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease

> **NCT01811381** · PHASE2 · UNKNOWN · sponsor: **VA Office of Research and Development** · enrollment: 80 (estimated)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Curcumin
- **BEHAVIORAL:** aerobic yoga
- **BEHAVIORAL:** non aerobic yoga
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01811381
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-20
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811381, "Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01811381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*